Abstract Details
|
David R. Benavides, MD, PhD, FÂ鶹´«Ã½Ó³»
(University of Maryland School of Medicine)
PRESENTER |
The institution of Dr. Benavides has received research support from NIH/NINDS. The institution of Dr. Benavides has received research support from F. Hoffman La Roche Ltd. |
| John Probasco, MD, FÂ鶹´«Ã½Ó³» (The Johns Hopkins Hospital) | Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech. |
| No disclosure on file | |
| Angela Wabulya, MB ChB (Mayo Clinic Arizona) | Dr. Wabulya has nothing to disclose. |
| No disclosure on file | |
| Gregory K. Bergey, MD, FÂ鶹´«Ã½Ó³» | Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. |
| Peter W. Kaplan, MBBS, FRCP, FÂ鶹´«Ã½Ó³» (Johns Hopkins Bayview) | Dr. Kaplan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DNP Epiwatch. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for IFCN. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Kaplan has received publishing royalties from a publication relating to health care. |